Evidence of differential microbiomes in healing versus non‐healing diabetic foot ulcers prior to and following foot salvage therapy

Diabetic foot ulcers (DFU) contribute to 80% of lower extremity amputations. Although physicians currently rely on clinical signs along with non‐specific biomarkers of infection, such as erythrocyte sedimentation rate and C‐reactive protein, to diagnose and monitor DFU, there is no specific and sensitive measure available to monitor or prognosticate the success of foot salvage therapy (FST). To address this we performed a prospective, observational microbiome analysis to test the hypotheses that: (i) the initial microbiomes of healed versus non‐healed DFU are distinct; (ii) the microbial load, diversity and presence of pathogenic organism of the DFU change in response to antibiotics treatment; and (iii) the changes in the DFU microbiome during treatment are prognostic of clinical outcome. To test this, microbiome analyses were performed on 23 DFU patients undergoing FST, in which wound samples were collected at zero, four, and eight weeks following wound debridement and antibiotics treatment. Bacterial abundance was determined using quantitative polymerase chain reaction (qPCR). Eleven patients healed their DFU, while FDT failed to heal DFU in the other 12 patients. Microbiome results demonstrated that healing DFUs had a larger abundance Actinomycetales and Staphylococcaceae (p < 0.05), while DFUs that did not heal had a higher abundance of Bacteroidales and Streptococcaceae (p < 0.05). FST marked increases Actinomycetales in DFU, and this increase is significantly greater in patients that healed (p < 0.05). Future studies to confirm the differential microbiomes, and that increasing Actinomycetales is prognostic of successful FST are warranted. Statement of Clinical Significance: Tracking changes in the prevalence of pathogens in diabetic foot ulcers may be a clinical tool for monitoring treatment response to foot salvage therapy and prognosticating the need for further surgical intervention. The initial wound sample microbiome may provide important prognostic information on the eventual clinical outcome of foot salvage therapy. It may serve as an important clinical tool for patient counseling and making surgical decision of pursuing foot salvage versus amputation. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 37:1596–1603, 2019.

[1]  H. Rohde,et al.  2018 international consensus meeting on musculoskeletal infection: Summary from the biofilm workgroup and consensus on biofilm related musculoskeletal infections , 2019, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[2]  S. Gill,et al.  Tracking Anti-Staphylococcus aureus Antibodies Produced In Vivo and Ex Vivo during Foot Salvage Therapy for Diabetic Foot Infections Reveals Prognostic Insights and Evidence of Diversified Humoral Immunity , 2018, Infection and Immunity.

[3]  B. Scola,et al.  The diabetic foot microbiota: A review , 2017 .

[4]  J. Black,et al.  Burden of Infected Diabetic Foot Ulcers on Hospital Admissions and Costs. , 2016, Annals of vascular surgery.

[5]  K. Dhatariya,et al.  Factors determining the risk of diabetes foot amputations--A retrospective analysis of a tertiary diabetes foot care service. , 2016, Diabetes research and clinical practice.

[6]  S. Gill,et al.  The effect of antibiotics on the microbiome in acute exacerbations of chronic rhinosinusitis , 2015, International forum of allergy & rhinology.

[7]  P. Gajer,et al.  An improved dual-indexing approach for multiplexed 16S rRNA gene sequencing on the Illumina MiSeq platform , 2014, Microbiome.

[8]  J. Segre,et al.  The Neuropathic Diabetic Foot Ulcer Microbiome Is Associated With Clinical Factors , 2013, Diabetes.

[9]  Benjamin A Lipsky,et al.  Diabetic Foot Ulcer Microbiome: One Small Step for Molecular Microbiology . . . One Giant Leap for Understanding Diabetic Foot Ulcers? , 2013, Diabetes.

[10]  David G Armstrong,et al.  2012 infectious diseases society of america clinical practice guideline for the diagnosis and treatment of diabetic foot infections. , 2013, Journal of the American Podiatric Medical Association.

[11]  A. Mukherjee,et al.  Statistical reliability of bone biopsy for the diagnosis of diabetic foot osteomyelitis. , 2011, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[12]  Evan S Snitkin,et al.  Longitudinal shift in diabetic wound microbiota correlates with prolonged skin defense response , 2010, Proceedings of the National Academy of Sciences.

[13]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[14]  J. Ravel,et al.  Community Analysis of Chronic Wound Bacteria Using 16S rRNA Gene-Based Pyrosequencing: Impact of Diabetes and Antibiotics on Chronic Wound Microbiota , 2009, PloS one.

[15]  David Aron,et al.  Mortality rates and diabetic foot ulcers: is it time to communicate mortality risk to patients with diabetic foot ulceration? , 2008, Journal of the American Podiatric Medical Association.

[16]  R. Frantz,et al.  Wound Bioburden and Infection-Related Complications in Diabetic Foot Ulcers , 2008, Biological research for nursing.

[17]  W. Jeffcoate,et al.  Controversies in diagnosing and managing osteomyelitis of the foot in diabetes. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  B. Barrell,et al.  Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) , 2002, Nature.

[19]  Benjamin A Lipsky Osteomyelitis of the foot in diabetic patients. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Calhoun,et al.  Treatment of Diabetic Foot Infections: Wagner Classification, Therapy, and Outcome , 1988, Foot & ankle.

[21]  S. Waksman,et al.  PRODUCTION OF ANTIBIOTIC SUBSTANCES BY ACTINOMYCETES *† , 1946, Annals of the New York Academy of Sciences.

[22]  Yakup Çelik,et al.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration , 2014, Wiener klinische Wochenschrift.

[23]  Charles L. Saltzman,et al.  Mann's surgery of the foot and ankle , 2013 .

[24]  David G. Armstrong,et al.  Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa , 2012 .

[25]  T. Elamurugan,et al.  Role of bone biopsy specimen culture in the management of diabetic foot osteomyelitis. , 2011, International journal of surgery.

[26]  Y. Yazdanpanah,et al.  Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  R. Frantz,et al.  A tool to assess clinical signs and symptoms of localized infection in chronic wounds: development and reliability. , 2001, Ostomy/wound management.